Literature DB >> 6610622

Correlation of aberrant proliferation with T-cell growth factor in adult T-cell leukemia cells.

H Tsuda, K Takatsuki.   

Abstract

Peripheral blood lymphocytes from seven patients with adult T-cell leukemia (ATL) were found to lack PHA-responsiveness. However, in most of the cases, minute but distinct proliferation could be induced and maintained by human spleen cell conditioned medium containing PHA or by a combination of PHA and conditioned medium of gibbon cell line, MLA-144 (MLA-144 CM). These results indicate that the lack of response to mitogens of ATL cells might be attributed not only to the failure of these cells to produce T-cell growth factor (TCGF) upon activation, but also to their poor responsiveness to TCGF. Furthermore, a direct proliferative response to mitogen-free MLA-144 CM was shown in two out of seven patients; these two patients experienced rapidly progressive clinical courses. This observation raises the possibility that TCGF promotes the growth of ATL cells in vivo, and is related to the clinical course of the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6610622     DOI: 10.1002/hon.2900010208

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  4 in total

1.  Abnormal expression pattern of Tac and T9 antigens on in vitro activation of leukemic T cells.

Authors:  H Tsuda; K Takatsuki
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

2.  Specific decrease in T3 antigen density in adult T-cell leukaemia cells: I. Flow microfluorometric analysis.

Authors:  H Tsuda; K Takatsuki
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

3.  Spontaneous production of interleukin 6 by adult T-cell leukaemia cells.

Authors:  T Sawada; H Tsuda; K Takatsuki
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

4.  Interleukin-2 prevents programmed cell death in adult T-cell leukemia cells.

Authors:  H Tsuda; R W Huang; K Takatsuki
Journal:  Jpn J Cancer Res       Date:  1993-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.